Hepatic artery thrombosis after orthotopic liver transplantation: A review of nonsurgical causes

Liver Transplantation

Volumn 7, Issue 2, 2001, Pages 75-81

  Pastacaldi, Sabrina ^a   Teixeira, Rosangela ^a   Montalto, Paolo ^a   Rolles, Keith ^a   Burroughs, Andrew K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; IMMUNOLOGIC FACTOR; LIPOPROTEIN; PROCOAGULANT; PROTEIN C; PROTEIN S; UNIVERSITY OF WISCONSIN SOLUTION; VON WILLEBRAND FACTOR;

AGE; ALLOGRAFT; ARTERY ANASTOMOSIS; ARTERY ENDOTHELIUM; ARTERY THROMBOSIS; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DONOR; ENDOTHELIUM CELL; FIBRINOLYSIS; GRAFT PRESERVATION; HEMOSTASIS; HEPATIC ARTERY; HUMAN; HYPERCOAGULABILITY; LATENT VIRUS INFECTION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; REVIEW; RISK FACTOR; SMOKING; SURGICAL TECHNIQUE; TOBACCO; VIREMIA;

EID: 0035114807     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2001.22040     Document Type: Article

References (65)

1. Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation
2. Hepatic artery complications after liver transplantation
3. Vascular complications after orthotopic liver transplantation
4. Hepatic artery thrombosis in infants. A comparison of whole livers, reduced-size grafts, and grafts from living-related donors
5. Hepatic artery thrombosis after pediatric liver transplantation: A medical or surgical event?
6. Factors responsible for hepatic artery thrombosis after pediatric liver transplantation
7. Etiology and management of symptomatic adult hepatic artery thrombosis after orthotopic liver transplantation (OLT)
8. Problematic vascular reconstruction in liver transplantation
9. Prevention of biliary cirrhosis following hepatic arterial thrombosis after liver transplantation in children by using ursodeoxycholic acid
10. The use of the supraceliac aorta for hepatic arterial revascularization in transplantation of the liver
11. Selective hepatic artery ligation: Limitations and failures
12. Late hepatic artery thrombosis in liver allograft recipients is associated with intrahepatic biliary necrosis
13. Portal and arterial thrombosis in liver transplantation: A frequent event in severe rejection
14. Increased bile duct complications in liver transplantation across the ABO barrier
15. The use of ABO-incompatible grafts in liver transplantation: A life-saving procedure in highly selected patients
16. Hepatic artery thrombosis in living related liver transplantation
17. Hepatic artery thrombosis (HAT) after orthotopic transplantation (OLT)- The influence of technical factors and rejection episodes
18. The impact of microsurgical hepatic arterial reconstruction on the outcome of liver transplantation for congenital biliary atresia
19. Early vascular complications after pediatric liver transplantation
20. Increased hepatic artery thrombosis and decreased liver graft survival with zero CREG mismatches
21. Urgent revascularization of liver allografts after early hepatic artery thrombosis
22. Prolonged preservation in University of Wisconsin solution associated with hepatic artery thrombosis after orthotopic liver transplantation
23. Graft loss and the antiphospholipid syndrome following liver transplantation
24. Low haematocrit reduces hepatic artery thrombosis after liver transplantation
25. Acquired protein S deficiency with multiple thrombotic complications after orthotopic liver transplantation
26. Mutation in blood coagulation factor V associated with resistance to activated protein C
27. Factor V Leiden presenting as recurrent mesenteric artery thrombosis
28. Liver transplantation in a patient with acute liver failure due to sickle cell intrahepatic cholestasis
29. Thrombosis of the hepatic artery and portal vein secondary to invasive aspergillosis following liver transplantation
30. Human herpes virus-6 infection after liver transplantation
31. An analysis of late hepatic artery thrombosis after orthotopic liver transplant
32. Implication of advanced donor age on the outcome of liver transplantation
33. Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era
34. In vitro inhibition of platelet aggregation by the liver with UW solution as the preservation fluid
35. Extended preservation of human liver grafts with UW solution
36. Preservation of livers with UW or Euro-Collins solution
37. Impaired endothelium-dependent relaxation of human hepatic arteries after preservation with the University of Wisconsin solution
38. High prevalance of anti-cardiolipin and other autoantibodies in a healthy elderly population
39. Anticardiolipin antibodies and hepatic artery thrombosis after liver transplantation
40. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
41. The factor V Leiden mutation: A possible contributor to the hepatic artery thrombosis encountered after liver transplantation in a child
42. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation
43. Predictive value of von Willebrand factor to ristocetin cofactor ratio and thrombin-anti-thrombin complex levels for hepatic vessel thrombosis and graft rejection after liver transplantation
44. Von Willebrand factor is an acute phase reactant in man
45. Unusually large plasma factor VIII:von Willebrand facotr multimers in chronic relapsing thrombotic thrombocytopenic purpura
46. Association of early CMV viraemia with hepatic artery thrombosis
47. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients
48. Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation
49. Cytomegalovirus and atherosclerosis
50. Cytomegalovirus and latency: An overview
51. Cytomegalovirus antigen within human arterial smooth muscle cells
52. The procoagulant response of cytomegalovirus infected endothelial cells
53. Membrane related effects in endothelial cells induced by human cytomegalovirus
54. Case report: Cytomegalovirus infection as a cause of acute portal vein thrombosis
55. Ischemic colitis secondary to venous thrombosis. A rare presentation of cytomeg-alovirus vasculitis following renal transplantation
56. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells
57. Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers
58. Induction of endothelial cell procoagulant activity by cytomegalovirus infection
59. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression
60. Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor
61. Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology
62. Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: An atherogenic link?
63. Use of polymerase chain reaction to provide prognostic information on human cytomegalovirus disease after liver transplantation
64. Hepatic allograft abscess with hepatic arterial thrombosis
65. Hepatic artery thrombosis resulting in gas gangrene of the transplanted liver